Fibrates

Results: 99



#Item
61Volume 27 (1), 2007 Editors Barbara Cadario, B.Sc.(Hon), B.Sc.Phm., M.Sc. Karen L.A. Wlock, B.Sc.(Pharm.)  Contents

Volume 27 (1), 2007 Editors Barbara Cadario, B.Sc.(Hon), B.Sc.Phm., M.Sc. Karen L.A. Wlock, B.Sc.(Pharm.) Contents

Add to Reading List

Source URL: dpic.org

Language: English - Date: 2013-06-09 23:16:55
62The Endocrine Society’s  	Clinical Guidelines

The Endocrine Society’s Clinical Guidelines

Add to Reading List

Source URL: www.endocrine.org

Language: English - Date: 2013-05-26 14:54:41
63HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ANTARA® safely and effectively. See full prescribing information for ANTARA. ANTARA (fenofibrate) Capsules, for ora

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ANTARA® safely and effectively. See full prescribing information for ANTARA. ANTARA (fenofibrate) Capsules, for ora

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-12-21 15:44:52
64HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRIGLIDE® safely and effectively. See full prescribing information for TRIGLIDE.   TRIGLIDE (fenofibrate) Tablets,

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRIGLIDE® safely and effectively. See full prescribing information for TRIGLIDE.   TRIGLIDE (fenofibrate) Tablets,

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-01-22 11:19:29
65HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FENOGLIDE® safely and effectively. See full prescribing information for FENOGLIDE. FENOGLIDE (fenofibrate) Tablets,

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FENOGLIDE® safely and effectively. See full prescribing information for FENOGLIDE. FENOGLIDE (fenofibrate) Tablets,

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-11-02 15:43:28
66The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

Add to Reading List

Source URL: www.fda.gov

Language: English
67Dn2189v1-proposed-simcor-2010-oct-20 SIMCOR - simvastatin and niacin tablet, film coated, extended release Abbott Laboratories[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION  These highlights do not include all the infor

Dn2189v1-proposed-simcor-2010-oct-20 SIMCOR - simvastatin and niacin tablet, film coated, extended release Abbott Laboratories[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the infor

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-03-04 07:44:55
681) Please comment on the findings of glucose intolerance and development of diabetes associated with Egrifta (tesamorelin) therapy and its impact on long-term cardiovascular risk

1) Please comment on the findings of glucose intolerance and development of diabetes associated with Egrifta (tesamorelin) therapy and its impact on long-term cardiovascular risk

Add to Reading List

Source URL: www.fda.gov

Language: English
69Document ID: neg-lbl-0859 Status: Internally Approved Generic Name: Niacin and Simvastatin Version: 2.0, CURRENT Internal Approval Date: [removed]

Document ID: neg-lbl-0859 Status: Internally Approved Generic Name: Niacin and Simvastatin Version: 2.0, CURRENT Internal Approval Date: [removed]

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-06-27 14:56:48
70DEFYING CONVENTIONAL WISDOM: THE CASE FOR PRIVATE ANTITRUST ENFORCEMENT Joshua P. Davis & Robert H. Lande1 CASE SUMMARIES 1. 3M (Meijer, Inc. v. 3M)

DEFYING CONVENTIONAL WISDOM: THE CASE FOR PRIVATE ANTITRUST ENFORCEMENT Joshua P. Davis & Robert H. Lande1 CASE SUMMARIES 1. 3M (Meijer, Inc. v. 3M)

Add to Reading List

Source URL: www.antitrustinstitute.org

Language: English - Date: 2013-10-07 04:42:13